E2F4 and breast cancer: Interestingly, cell cycle-associated proteins, such as the cyclin-dependent kinases (CDKs) and the E2F4 oncogenes appeared to be strongly dysregulated between subgroups, displaying an increased activity in the most severe breast cancer subtype, Basal-l (Appendix Fig. S8).